Cargando…
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
Mass-spectrometry-based proteomic data on human tumors—combined with corresponding multi-omics data—present opportunities for systematic and pan-cancer proteogenomic analyses. Here, we assemble a compendium dataset of proteomics data of 2002 primary tumors from 14 cancer types and 17 studies. Protei...
Autores principales: | Zhang, Yiqun, Chen, Fengju, Chandrashekar, Darshan S., Varambally, Sooryanarayana, Creighton, Chad J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106650/ https://www.ncbi.nlm.nih.gov/pubmed/35562349 http://dx.doi.org/10.1038/s41467-022-30342-3 |
Ejemplares similares
-
Author Correction: Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
por: Zhang, Yiqun, et al.
Publicado: (2022) -
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
por: Chen, Fengju, et al.
Publicado: (2019) -
Global impact of somatic structural variation on the cancer proteome
por: Chen, Fengju, et al.
Publicado: (2023) -
Pan-cancer molecular subtypes of metastasis reveal distinct and evolving transcriptional programs
por: Zhang, Yiqun, et al.
Publicado: (2023) -
Global molecular alterations involving recurrence or progression of pediatric brain tumors
por: Chen, Fengju, et al.
Publicado: (2021)